G. Zuniga et al., MICRONUCLEATED ERYTHROCYTES IN SPLENECTOMIZED PATIENTS WITH AND WITHOUT CHEMOTHERAPY, Mutation research. Section on environmental mutagenesis and related subjects, 361(2-3), 1996, pp. 107-112
The purpose of the present study was to investigate the range of micro
nucleated erythrocytes (MNE) in peripheral blood from splenectomized p
atients with and without genotoxic chemotherapy. The erythrocytes were
stained with Wright and Giemsa for microscopic observation, To estima
te the number of MNE, two series of 10 000 erythrocytes per sample wer
e analyzed and averaged. The results expressed as mean +/- standard de
viation were as follows: control patients with genotoxic chemotherapy
(n = 6) 2.5 +/- 1.5 (range 1 to 5 MNE); splenectomized patients with g
enotoxic chemotherapy (n = 7) 65.2 +/- 17.7 (range: 47-108) MNE and sp
lenectomized patients without genotoxic chemotherapy (it = 13) 29.5 +/
- 5.8 MNE; (range: 18.5-35.6), The MNE number in the patients treated
with genotoxic chemotherapy depended on the type of drugs utilized: cy
clophosphamide, mitoxantrone, vincristine, busulphan, cytosine arabino
side and hydroxyurea. Upon these results, it is suggested that splenec
tomized people could be useful in monitoring exposures, and the baseli
ne MNE level would serve as each persons pre-exposure control when eit
her chronic or acute exposure to environmental mutagens is investigate
d.